Eschbach Wins Pharmaceutical Technology Excellence Award for Innovation and AI

eschbach, developer of Shiftconnector®, an intelligent operations platform for the pharmaceutical industry, has won the prestigious Pharmaceutical Technology Excellence Award —in two categories: for their innovation in operating intelligence with real-time visualization and the launch of collaborative AI features. 

eschbach is pleased to announce that to have been recognized with two awards in the 2025 Pharmaceutical Technology Excellence Awards—one of the industry's most prestigious global recognition programs. This includes the Innovation Award for Operational Intelligence and the Product Launches Award for the integration of eschbach's AI assistant, SAMI, into the Shiftconnector® platform.

"We are honored to be recognized in not only one, but two categories within the pharmaceutical technology industry. This is a testament to the incredible work everyone at eschbach has put into Shiftconnector® and will serve as further motivation to grow and push the boundaries on what software can do in manufacturing," said Andreas Eschbach, Founder and CEO of eschbach.

These awards highlight the progress that eschbach has made in transforming how pharmaceutical plants manage and act on data in real time. In today's reindustrializing pharmaceutical landscape, the ability to turn fragmented data into timely, compliant decisions is now essential to success.